Barbara Oil Co’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.95M Hold
5,245
1.14% 29
2025
Q4
$3.55M Hold
5,245
1.32% 24
2025
Q3
$3.35M Sell
5,245
-3,250
-38% -$1.97M 1.25% 25
2025
Q2
$4.56M Hold
8,495
1.79% 17
2025
Q1
$3.57M Hold
8,495
1.45% 23
2024
Q4
$3.51M Hold
8,495
1.46% 24
2024
Q3
$4.29M Hold
8,495
1.75% 18
2024
Q2
$4.14M Hold
8,495
1.81% 18
2024
Q1
$4.59M Hold
8,495
1.94% 15
2023
Q4
$4.72M Hold
8,495
2.12% 12
2023
Q3
$3.71M Hold
8,495
1.76% 17
2023
Q2
$4.27M Hold
8,495
1.96% 14
2023
Q1
$4.25M Hold
8,495
2.04% 13
2022
Q4
$3.47M Hold
8,495
1.66% 19
2022
Q3
$2.77M Hold
8,495
1.52% 20
2022
Q2
$2.98M Hold
8,495
1.54% 22
2022
Q1
$4.65M Hold
8,495
2.13% 12
2021
Q4
$5.59M Hold
8,495
2.42% 11
2021
Q3
$5.28M Hold
8,495
2.48% 10
2021
Q2
$5.37M Hold
8,495
2.47% 11
2021
Q1
$4.16M Buy
+8,495
New +$4.26M 2% 14
2019
Q4
Sell
-9,000
Closed -$2.45M 91
2019
Q3
$2.45M Buy
+9,000
New +$2.5M 1.38% 23

Other funds holding IDXX

Barbara Oil Co's IDXX Position: Q1 2026 in Review

Barbara Oil Co held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 5,245 shares worth $2.95M. The position accounts for 1.14% of the portfolio, ranked #29.

Barbara Oil Co first reported a position in IDXX in Q3 2019 and has held it in 22 quarters since. The position peaked at $5.59M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Barbara Oil Co held 5,245 shares of Idexx Laboratories worth $2.95M as of Q1 2026.
  • Barbara Oil Co left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 1.14% of Barbara Oil Co's portfolio in Q1 2026, its #29 holding.
  • Barbara Oil Co first reported a position in Idexx Laboratories in Q3 2019 and has held it in 22 quarters since.
  • Barbara Oil Co's Idexx Laboratories position peaked at $5.59M in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Barbara Oil Co's 13F filing for Q1 2026, filed 13 May 2026.